Company intelligence / Profile preview

Vibalogics

Boxborough, Massachusetts, United Statesrecipharm.com ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Vibalogics does not develop its own clinical candidates but provides end-to-end process development, analytical testing, GMP manufacturing, and fill-finish services for viral vectors and live viruses used in gene therapies, oncolytic viruses, and vaccines. The company has expanded to support late-stage clinical and commercial production with state-of-the-art facilities in the US and Germany

Therapeutic areas: Infectious Diseases
Modalities: Viral vectorLive virusmRNA-based drugsPlasmid DNALipid nanoparticle delivery therapy
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Vibalogics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibalogics.

Explore the full profile